Substance Use Disorder

The WSMA supports promoting research and attempts to better recognize and address within the medical profession implicit bias and stigma regarding patients who have substance use disorder. (Res C-8, A-18)

The WSMA supports policy that requires any state-licensed entity providing care for substance use disorders to have a medical director at the doctorate level with one of the essential duties of the medical director being to help ensure that individuals are informed of and have access to pertinent FDA-approved therapies as well as other evidence-based interventions. (Res C-19, A-18)

Return to the WSMA Policy Compendium index

Abbreviations for House of Delegates report origination:

EC – Executive Committee; BT – Board of Trustees; CPA – Council on Professional Affairs; JC – Judicial Council; CHS – Community and Health Services